Verrica Pharmaceuticals (VRCA) Earnings Date & Reports
Verrica Pharmaceuticals Inc is a therapeutics company developing and commercializing medications for the treatment of dermatologic diseases, including skin cancers... Show more
VRCA is expected to report earnings to rise 1.61% to -62 cents per share on November 13
Q3'26
Est.
$-0.63
Q2'26
Missed
by $0.22
Q1'26
Missed
by $0.03
Q4'25
Missed
by $0.51
Q3'25
Beat
by $0.21
The last earnings report on August 06 showed earnings per share of -62 cents, missing the estimate of -39 cents. With 8.80K shares outstanding, the current market capitalization sits at 60.64M.